See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 28, 2006

Hypertension (High Blood Pressure) Human Papilloma Virus (HPV) Type 2 Diabetes

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Hypertension (High Blood Pressure)

This study, which will last about 14 weeks, will assess the safety and efficacy of the study medication compared with a currently marketed medication in people with systemic hypertension. To be eligible, you must be at least 18 years old and have high blood pressure.

The research site is in Gilbert, Ariz.

More information

Please see http://www.centerwatch.com/patient/studies/cat85.html.

-----

Human Papilloma Virus (HPV)

This study will evaluate an investigational gel applied intravaginally to treat HPV. Women 18-40 may qualify who are willing to be on an acceptable method of birth control, are of child-bearing potential, and have had a screening pap test that shows low-grade squamous intraepithelial lesions (LSIL) or atypical squamous cells of undetermined significance (ASC-US). Other criteria may apply.

The research site is in Montgomery, Ala.

More information

Please see http://www.centerwatch.com/patient/studies/cat421.html.

-----

Type 2 Diabetes

This 14-week study will evaluate the safety and effectiveness of the study medication compared with another marketed drug to treat type 2 diabetes. To be eligible, you must be between 18 and 80, diagnosed with type 2 diabetes, and on diabetes medication that is not adequately controlling the disease.

The research site is in Gilbert, Ariz.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News
undefined
undefinedundefined